Back to
XTX Topco Ltd
REGNShowing 7 of 20 quarters
Position history for
XTX Topco Ltd's holdings in Regeneron Pharmaceuticals, Inc.
Yes. XTX Topco holds 30,522 shares of REGN (Regeneron Pharmaceuticals), worth $19M, as of its Q2 2026 13F filing. It increased the position from 319 shares in Q1 2026. XTX Topco has held REGN since Q1 2026, across 2 quarterly 13F filings. REGN is 0.2% of XTX Topco's reported 13F portfolio.
Current Value
$19M
Current Shares
30,522
Total Value Change
+$18.2M
Total Shares Change
+29,716
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC